2026 NPPES data Medical Oncology Physician NPI 1073921169 M.D.
Verify on CMS →

SHAJADI PATAN, M.D.

Medical Oncology Physician in KANSAS CITY, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
513
Medicare Part D claims · 133 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$715.2
30 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SHAJADI PATAN, M.D. is a Medical Oncology Physician ([object Object]) practicing in KANSAS CITY, Missouri with a Medicare Part D prescribing footprint of 513 claims across 133 beneficiaries — 11% brand-name prescribing . Industry payments of $715.2 across 30 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SHAJADI PATAN, M.D. filed 513 Medicare Part D claims in 2023 across KANSAS CITY, Missouri. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

SHAJADI PATAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

SHAJADI PATAN, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 08/01/2014

NPI 1073921169

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

513 26% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Missouri

How Medical Oncology Physician compares to other specialties among Missouri providers

Missouri providers

Medical Oncology Physician share within Missouri

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Missouri

Specialty board-certification context

Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Medical Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SHAJADI PATAN, M.D. is a Medical Oncology Physician provider practicing in KANSAS CITY, Missouri, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1073921169. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SHAJADI PATAN, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 2316 E MEYER BLVD, KANSAS CITY, MO, 64132, with a listed phone of (816) 974-5050. NPI 1073921169 was issued on 08/01/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PATAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 513 prescription claims written by this provider, covering 133 Medicare beneficiaries and totaling roughly $902K in drug spend, split 11% brand-name and 89% generic by claim count, with an opioid prescribing rate of 9.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2316 E MEYER BLVD
KANSAS CITY, MO 64132

Provider Details

NPI 1073921169
Specialty Medical Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 08/01/2014

Hospital and facility affiliations

Facilities where SHAJADI PATAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

WESTERN MISSOURI MEDICAL CENTER
★★★★☆ 4/5
WARRENSBURG, MO
Acute Care Hospitals
CMS CCN: 260097
AMERICAN ONCOLOGY PARTNERS PA
BELTON, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SHAJADI PATAN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$715

Largest payer

Merck Sharp & Dohme LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

SHAJADI PATAN, M.D. — brand share 11.0%
Specialty average (est.)

11% brand-name claims vs 89% generic, on 513 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

513
Total Claims
$902K
Total Drug Cost
133
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
674
Total Day Supply
18,478
Brand vs Generic
11% brand / 89% generic
Brand Drug Cost
$744K
Generic Drug Cost
$158K
Opioid Claims
47 (9.2% rate)
Antibiotic Claims
12

Patient Demographics

Average Patient Age
71.0 years
Avg HCC Risk Score
1.97
Gender Split
74% female / 26% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Letrozole
80
Anastrozole
49
Prednisone
37
Warfarin Sodium
29
Gabapentin
25
Abiraterone Acetate
24
Hydroxyurea
19
Oxycodone Hcl
17
Lorazepam
13
Ondansetron Odt
Ondansetron
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How SHAJADI PATAN, M.D. fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

SHAJADI PATAN, M.D.'s 513 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as PATAN.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SHAJADI PATAN, M.D.'s specialty?
SHAJADI PATAN, M.D. specializes in Medical Oncology Physician and practices in KANSAS CITY, Missouri. Credentials: M.D..
How much does SHAJADI PATAN, M.D. prescribe under Medicare Part D?
In 2023, SHAJADI PATAN, M.D. wrote 513 Medicare Part D claims totaling $902K in drug costs for 133 beneficiaries.
Where is SHAJADI PATAN, M.D. located?
SHAJADI PATAN, M.D. is located at 2316 E MEYER BLVD, KANSAS CITY, MO, 64132. Phone: (816) 974-5050.
What is SHAJADI PATAN, M.D.'s NPI number?
SHAJADI PATAN, M.D.'s National Provider Identifier (NPI) is 1073921169, issued on 08/01/2014.
Does SHAJADI PATAN, M.D. prescribe more brand-name or generic drugs?
SHAJADI PATAN, M.D.'s prescribing is 11% brand-name and 89% generic drugs by claim count, with $744K in brand drug costs.
Does SHAJADI PATAN, M.D. prescribe opioids?
Yes, SHAJADI PATAN, M.D. had 47 opioid claims in 2023 with an opioid prescribing rate of 9.2%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does SHAJADI PATAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SHAJADI PATAN, M.D.'s most frequently prescribed drugs include Letrozole, Anastrozole, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SHAJADI PATAN, M.D. accept Medicare?
SHAJADI PATAN, M.D. appears in CMS Medicare data with 513 Part D claims and 133 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SHAJADI PATAN, M.D.'s credentials?
SHAJADI PATAN, M.D.'s NPI is 1073921169 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology